Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells
Author:
C.Jeffrey Smith,Hariprasad Gali,Gary L. Sieckman,Donald L. Hayes,Nellie K. Owen,Dana G. Mazuru,Wynn A. Volkert,Timothy J. Hoffman
Publication:
Nuclear Medicine and Biology
Copyright © 2003 Elsevier Science Inc. All rights reserved.